Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Transplant Proc ; 44(7): 2007-12, 2012 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-22974894

RESUMO

PURPOSE: Despite the remarkable advances with the use of ventricular assist devices (VAD) in adults, pneumatic pulsatile support in children is still limited. We report on our experience in the pediatric population. METHODS: Retrospective review of 27 consecutive children offered mechanical support with Berlin Heart as a bridge to heart transplant, and Jarvik 2000 as a destination therapy from February 2002 to October 2011. RESULTS: The median patient age was 4.8 years (range = 75 days to 20.5 years). The median patient weight was 18.6 kg (range = 2.9-63 kg). We divided the patients in two groups, including in group I patients assisted for bridging to heart transplantation and in group II patients with Duchenne's dystrophy assisted as destination therapy. In the group I, 11 patients required biventricular mechanical support (BVAD), but in all other cases, a single left VAD proved sufficient (56%). The median duration of VAD support was 48 days (1 to 192 days). The median pre-VAD pulmonary vascular resistance index (Rpi) was 5.7 WU/m(2) (3.5 to 14.4 WU/m(2)). Twelve patients (48%) were successfully bridged to heart transplantation after a median duration of mechanical support of 63 days (range = 2-168 days). Ten deaths occurred (40%), three for neurological complications, two for sepsis, two for multiorgan failure, and three other for device malfunctioning. Since 2007, the survival rate of our patients has increased from 33% to 75%, and the need for BVAD has decreased from 89% to 23%. In the group II, two patients with mean age of 15.3 years were assisted with Jarvik 2000, and both of them are alive in a follow-up of 10.4 months. In two patients with Rpi > 10 WU/m(2), unresponsive to pulmonary vasodilatator therapy, Rpi dropped to 2.2 and 2 WU/m(2) after 40 and 23 days of BVAD support, respectively. Six patients (32%) required at least one pump change. Of 12 patients undergoing heart transplantation, five developed an extremely elevated (>60%) panel-reactive antibody by enzyme-linked immunosorbent assay, confirmed by Luminex. All of them experienced at least one acute episode of rejection in the first month after heart transplant, needing plasmapheresis. The survival rate after heart transplantation was 100% with a median follow-up of 34.4 months (45 days to 8.7 years). CONCLUSIONS: Mechanical support in children with end-stage heart failure is an effective strategy as a bridge to heart transplantation with a reasonable morbidity and mortality. BVAD support may offer an additional means to reverse extremely elevated pulmonary vascular resistance. The total implantable system opens a future scenarios for patients not eligible for heart transplantation.


Assuntos
Transplante de Coração , Coração Auxiliar , Adolescente , Adulto , Criança , Pré-Escolar , Humanos , Lactente , Adulto Jovem
2.
Int J Cardiol ; 157(2): 212-5, 2012 May 31.
Artigo em Inglês | MEDLINE | ID: mdl-21194764

RESUMO

BACKGROUND: In patients with chronic mitral regurgitation (MR), undergoing surgical mitral valve repair, current Guidelines only recommend standard echocardiographic indices i.e. left ventricular (LV) ejection fraction (EF), and LV end-systolic and end-diastolic diameters as preoperative variables. However LV EF is often preserved until advanced stages of the valve disease. Aim of this study was to evaluate changes in LV systolic longitudinal function, 3 months after mitral valve repair in patients with chronic degenerative MR and normal preoperative EF. METHODS: We measured M-mode mitral lateral annulus systolic excursion (MAPSE) and Tissue Doppler (TD) peak systolic annular velocity (S(m)) in 31 patients with moderate to severe MR and normal EF (59.9 ± 4.7%) candidates for mitral valve repair, preoperatively and 3 months after surgery. RESULTS: After mitral valve repair, S(m) increased from 7.8 ± 1.4 to 9.6 ± 2.2 cm/s (p<0.0001) and MAPSE increased from 1.33 ± 0.26 to 1.55 ± 0.25 cm (p=0.0013). EF decreased from 59.9 ± 4.7 to 51.3 ± 5.9% (p<0.0001). As expected, LV diameters and volumes, wall thicknesses, midwall fractional shortening (mFS), and left atrial (LA) size were all reduced after surgery. CONCLUSIONS: This study suggests that assessment of LV long axis systolic velocity and amplitude of excursion by echocardiography is more sensitive than simple determination of EF for revealing the beneficial impact of MR surgery on overall systolic function.


Assuntos
Insuficiência da Valva Mitral/diagnóstico por imagem , Insuficiência da Valva Mitral/cirurgia , Valva Mitral/diagnóstico por imagem , Valva Mitral/cirurgia , Recuperação de Função Fisiológica/fisiologia , Função Ventricular Esquerda/fisiologia , Seguimentos , Humanos , Estudos Longitudinais , Valva Mitral/fisiopatologia , Insuficiência da Valva Mitral/fisiopatologia , Ultrassonografia
3.
Curr Drug Targets ; 12(2): 149-72, 2011 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-20887246

RESUMO

Triamcinolone acetonide (TA) is one of the first pharmacologic compounds evaluated for the treatment of choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD). The most important effects of TA consist in the stabilisation of the blood-retinal barrier and the down-regulation of inflammation. TA also has anti-angiogenic and anti-fibrotic properties. The peculiar characteristic of being well tolerated by ocular tissues and the capability to remain active for many months after a single intravitreal injection, make this drug a safe and effective alternative. In the past decade, intravitreal injection of TA (IVTA) has emerged as a useful treatment of several ocular diseases such as uveitis, macular edema secondary to retinal vasculature disease, neovascularisation and vitreoretinopathy. In this paper, we review all the available evidence of its use in AMD as mono-therapy or in combination with other treatments, and we discuss which role TA will play in the treatment of AMD in the future. The first experiences with IVTA as monotherapy for the treatment of exudative AMD reported a positive outcome in transiently reducing the leakage from CNV. However, in the long-term follow-up, IVTA as monotherapy had no effect on the risk of severe visual acuity loss, despite a significant anti-angiogenic effect found 3 months after the treatment. Consequently, studies using the combination of IVTA and photodynamic therapy (PDT), which acts synergistically, were performed. They reported to improve vision and to reduce the number of re-treatments with PDT. A large number of publications confirmed the positive synergic role of combining TA and PDT (therapies) for the treatment of all types of CNV: classic or predominantly classic, occult or minimally classic and RAP (Retinal Angiomatous Proliferation) lesions. The advantages registered with the use of IVTA plus PDT compared to PDT alone were partially limited by the side effects, such as the rapid evolution of cataract. Nevertheless, cataract surgery may stimulate the development of CNV (result in stimulating CNV). However, in large, randomized, clinical trials on combination therapy of TA and PDT, visual acuity failed to show an improvement, even though the lesion size and subretinal fluid had decreased, compared to controls treated with PDT alone. Some authors reported an increased risk of developing macular atrophy after the combination therapy with IVTA and PDT. Reduction of the PDT fluence rate in association with the use of steroids resulted in reducing the risk of macular atrophy and in a better visual acuity outcome. The introduction of anti-VEGF-based drugs has revolutionized the treatment of AMD and has replaced all the previous therapies used for CNV. Visual improvement becomes an expectation in a higher proportion of patients, previously limited to minimizing vision loss. Anti-VEGF therapy also resulted in superior visual improvement compared to all types of combination therapy with IVT and PDT. Nevertheless, anti-VEGF monotherapy also has many limitations due to the need of repetitive treatments, increased costs and tachyphylaxis. Treatment regimens involving TA in combination therapy with anti-VEGF and PDT may preserve benefits for substantially longer periods. A question remains open on whether a combination treatment with anti-VEGF, triamcinolone and/or PDT may be a treatment option in patients with exudative AMD, by offering, with one cycle of therapy, functional VA benefits comparable to those observed with continued monthly anti-VEGF therapy. Further trials, of higher scientific significance, are needed to study the potential of these treatment options.


Assuntos
Anti-Inflamatórios/uso terapêutico , Degeneração Macular/tratamento farmacológico , Triancinolona Acetonida/uso terapêutico , Inibidores da Angiogênese/efeitos adversos , Inibidores da Angiogênese/uso terapêutico , Animais , Anti-Inflamatórios/administração & dosagem , Anti-Inflamatórios/efeitos adversos , Anti-Inflamatórios/farmacologia , Cegueira/etiologia , Cegueira/prevenção & controle , Neovascularização de Coroide/tratamento farmacológico , Neovascularização de Coroide/etiologia , Neovascularização de Coroide/prevenção & controle , Terapia Combinada/efeitos adversos , Terapia Combinada/tendências , Preparações de Ação Retardada/efeitos adversos , Preparações de Ação Retardada/farmacologia , Preparações de Ação Retardada/uso terapêutico , Humanos , Hipertermia Induzida/efeitos adversos , Injeções Intravítreas , Degeneração Macular/metabolismo , Degeneração Macular/fisiopatologia , Degeneração Macular/terapia , Fotoquimioterapia/efeitos adversos , Fotoquimioterapia/tendências , Fármacos Fotossensibilizantes/efeitos adversos , Fármacos Fotossensibilizantes/farmacologia , Fármacos Fotossensibilizantes/uso terapêutico , Porfirinas/efeitos adversos , Porfirinas/farmacologia , Porfirinas/uso terapêutico , Triancinolona Acetonida/administração & dosagem , Triancinolona Acetonida/efeitos adversos , Triancinolona Acetonida/farmacologia , Fatores de Crescimento do Endotélio Vascular/antagonistas & inibidores , Fatores de Crescimento do Endotélio Vascular/metabolismo , Verteporfina , Degeneração Macular Exsudativa/tratamento farmacológico , Degeneração Macular Exsudativa/metabolismo , Degeneração Macular Exsudativa/fisiopatologia , Degeneração Macular Exsudativa/terapia
4.
Proc Natl Acad Sci U S A ; 97(5): 2259-63, 2000 Feb 29.
Artigo em Inglês | MEDLINE | ID: mdl-10681435

RESUMO

In this paper, we describe the neural changes observed in the primary motor cortex of two monkeys while they learned a new motor skill. The monkeys had to adapt their reaching movements to external forces that interfered with the execution of their arm movements. We found a sizable population of cells that changed their tuning properties during exposure to the force field. These cells took on the properties of neurons that are involved in the control of movement. Furthermore, the cells maintained the acquired activity as the monkey readapted to the no-force condition. Recent imaging studies in humans have reported the effects of motor learning in the primary motor cortex. Our results are consistent with the findings of these studies and provide evidence for single-cell plasticity in the primary motor cortex of primates.


Assuntos
Adaptação Fisiológica/fisiologia , Aprendizagem/fisiologia , Modelos Neurológicos , Córtex Motor/fisiologia , Animais , Meio Ambiente , Macaca nemestrina , Atividade Motora , Córtex Motor/citologia , Movimento , Plasticidade Neuronal/fisiologia
5.
J Neurophysiol ; 78(1): 554-60, 1997 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-9242306

RESUMO

The purpose of this study was to investigate the learning mechanisms underlying motor adaptation of arm movements to externally applied perturbing forces. We considered two alternative hypotheses. According to one, adaptation occurs through the learning of a mapping between the states (positions and velocities) visited by the arm and the forces experienced at those states. The alternative hypothesis is that adaptation occurs through the memorization of the temporal sequence of forces experienced along specific trajectories. The first mechanism corresponds to developing a model of the dynamics of the environment, whereas the second is a form of "rote learning." Both types of learning would lead to the recovery of the unperturbed performance. We have tested these hypotheses by examining how adaptation is transferred across different types of movements. Our results indicate that 1) adaptation to an externally applied force field occurs with different classes of movements including but not limited to reaching movements and 2) adaptation generalizes across different movements that visit the same regions of the external field. These findings are not compatible with the hypothesis of rote learning. Instead, they are consistent with the hypothesis that adaptation to changes in movement dynamics is achieved by a module that learns to reproduce the structure of the environmental field as an association between visited states and experienced forces, independent of the kinematics of the movements made during adaptation.


Assuntos
Adaptação Psicológica , Braço/fisiologia , Memória/fisiologia , Movimento/fisiologia , Adulto , Humanos , Aprendizagem/fisiologia , Dinâmica não Linear
6.
Minerva Chir ; 52(3): 243-5, 1997 Mar.
Artigo em Italiano | MEDLINE | ID: mdl-9148212

RESUMO

The authors comment the data from research on 70 patients with post cholecystectomy syndrome, using cholescintigraphy HIDA 99mTc to evaluate the relation ship between symptomatology (see classific.) and duodenogastric reflux entity. Cholescintigraphy seems to be a valid clinical means, especially for a correct indication to endoscopy.


Assuntos
Colecistectomia/efeitos adversos , Refluxo Duodenogástrico/diagnóstico por imagem , Vesícula Biliar/diagnóstico por imagem , Gastrite/diagnóstico por imagem , Iminoácidos , Compostos de Organotecnécio , Adulto , Idoso , Diagnóstico Diferencial , Endoscopia , Feminino , Humanos , Fígado/diagnóstico por imagem , Masculino , Pessoa de Meia-Idade , Cintilografia , Síndrome , Lidofenina Tecnécio Tc 99m
7.
Minerva Chir ; 52(3): 307-8, 1997 Mar.
Artigo em Italiano | MEDLINE | ID: mdl-9148223

RESUMO

Brucellosis may show itself only through its bone and muscle complications, especially in the lumbar region, such as vertebral colliquation or psoas abscess. The authors describe a case of brucellosis (56 year old male, butcher) with lumbar bone and muscle involvement. The first symptom was a persistent pain of the right lumbar region, with irradiation to the homolateral leg. At admission the patient showed a lumbar cutaneous fistula with pus-like secretion. Quick diagnosis and therapy can prevent irreparable damage, even when the symptoms are silent.


Assuntos
Doenças Ósseas/etiologia , Brucelose , Doenças Musculares/etiologia , Animais , Antibacterianos/uso terapêutico , Doenças Ósseas/diagnóstico , Brucelose/diagnóstico , Brucelose/tratamento farmacológico , Bovinos , Diagnóstico Diferencial , Doxiciclina/uso terapêutico , Humanos , Ílio , Vértebras Lombares , Masculino , Pessoa de Meia-Idade , Doenças Musculares/diagnóstico , Músculos Psoas , Rifampina/uso terapêutico , Irrigação Terapêutica
8.
Tumori ; 83(6): 958-9, 1997.
Artigo em Inglês | MEDLINE | ID: mdl-9526592

RESUMO

Cancer of the appendix was found in a 69-year-old female patient affected by long-standing ulcerative colitis (UC). On histological examination the cancer was a typical cystadenocarcinoma of the appendix. The appendiceal mucosa not invaded by the neoplastic process was normal. Histological examination of the colorectal mucosa did not show dysplasia or cancer. These findings suggest that appendiceal cancer and UC may be unrelated diseases. A surveillance program for early detection of cancer of the appendix in patients with long-standing UC does not seem mandatory.


Assuntos
Neoplasias do Apêndice/complicações , Colite Ulcerativa/complicações , Cistadenocarcinoma/complicações , Idoso , Neoplasias do Apêndice/patologia , Colite Ulcerativa/patologia , Cistadenocarcinoma/patologia , Feminino , Humanos
9.
Proc Natl Acad Sci U S A ; 93(9): 3843-6, 1996 Apr 30.
Artigo em Inglês | MEDLINE | ID: mdl-8632977

RESUMO

We investigated how human subjects adapt to forces perturbing the motion of their ams. We found that this kind of learning is based on the capacity of the central nervous system (CNS) to predict and therefore to cancel externally applied perturbing forces. Our experimental results indicate: (i) that the ability of the CNS to compensate for the perturbing forces is restricted to those spatial locations where the perturbations have been experienced by the moving arm. The subjects also are able to compensate for forces experienced at neighboring workspace locations. However, adaptation decays smoothly and quickly with distance from the locations where disturbances had been sensed by the moving limb. (ii) Our experiments also how that the CNS builds an internal model of the external perturbing forces in intrinsic (muscles and / or joints) coordinates.


Assuntos
Aprendizagem , Atividade Motora , Desempenho Psicomotor , Adulto , Braço , Sistema Nervoso Central/fisiologia , Lateralidade Funcional , Humanos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...